Travere Therapeutics (TVTX) Return on Capital Employed Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Travere Therapeutics | 4.34 Bn | 4.26 Bn | 102.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,218.00 |
| Dec 31, 2025 | 1,637.00 |
| Sep 30, 2025 | -806.00 |
| Jun 30, 2025 | -2,938.00 |
| Mar 31, 2025 | -3,650.00 |
| Dec 31, 2024 | -6,618.00 |
| Sep 30, 2024 | -8,476.00 |
| Jun 30, 2024 | -6,067.00 |
| Mar 31, 2024 | -6,058.00 |
| Dec 31, 2023 | -4,816.00 |
| Sep 30, 2023 | -4,108.00 |
| Jun 30, 2023 | -4,159.00 |
| Mar 31, 2023 | -4,399.00 |
| Dec 31, 2022 | -4,502.00 |
| Sep 30, 2022 | -3,791.00 |
| Jun 30, 2022 | -2,379.00 |
| Mar 31, 2022 | -1,818.00 |
| Dec 31, 2021 | -1,753.00 |
| Sep 30, 2021 | -2,365.00 |
| Jun 30, 2021 | -2,098.00 |
| Mar 31, 2021 | -2,325.00 |
| Dec 31, 2020 | -1,968.00 |
| Sep 30, 2020 | 74.00 |
| Jun 30, 2020 | 428.00 |
| Mar 31, 2020 | 1,601.00 |
| Dec 31, 2019 | 21,393.00 |
| Dec 31, 2018 | -16,757.00 |
| Mar 31, 2018 | 16,635.00 |